Centrum Medyczne Gamma Sp. z o.o.
- Address
- Ul. Wladyslawa Broniewskiego 3, 01-785 Warsaw, Poland
Centrum Medyczne Gamma Sp. z o.o.
Centrum Medyczne Gamma Sp. z o.o. is a clinical research facility specializing in musculoskeletal disorders and pain management research. The center conducts rigorous clinical investigations examining therapeutic interventions for degenerative joint conditions, with particular emphasis on evidence-based treatment strategies for patients suffering from chronic joint diseases.
- Knee osteoarthritis treatment and pain management studies
- Anti-inflammatory therapy research and biomarker analysis
- Synovial fluid cytokine profiling and pharmacokinetic studies
The center demonstrates expertise in conducting sophisticated placebo-controlled, double-blind clinical trials that investigate the biological mechanisms of nonsteroidal anti-inflammatory drugs (NSAIDs) in treating osteoarthritis. Their research includes advanced biomarker assessments, such as measuring Interleukin-6 (IL-6) concentrations in synovial fluid, to better understand drug efficacy and inflammatory pathways in joint disease. This comprehensive approach combines clinical outcome measures with detailed molecular analyses to advance understanding of osteoarthritis treatment.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne Gamma Sp. z o.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Naproxen Sodium on Synovial Fluid Cytokine Levels and Clinical Outcomes in Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial | KRKA tovarna zdravil d.d. Novo mesto | Phase III | Not Recruiting | May 2025 | Sep 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Naproxen Sodium | 1 | Unknown | 2025-05-21 | 2025-05-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.